Tredje AP fonden Sells 10,178 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Tredje AP fonden lowered its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 50.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 10,178 shares of the company’s stock after selling 10,178 shares during the period. Tredje AP fonden’s holdings in Henry Schein were worth $704,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Essential Planning LLC. acquired a new stake in shares of Henry Schein in the fourth quarter valued at approximately $934,000. Sequoia Financial Advisors LLC lifted its position in shares of Henry Schein by 7.2% during the 4th quarter. Sequoia Financial Advisors LLC now owns 6,109 shares of the company’s stock valued at $423,000 after acquiring an additional 412 shares during the period. HighTower Advisors LLC grew its holdings in shares of Henry Schein by 242.9% during the 4th quarter. HighTower Advisors LLC now owns 43,347 shares of the company’s stock worth $3,000,000 after purchasing an additional 30,706 shares in the last quarter. AGF Management Ltd. bought a new position in shares of Henry Schein in the fourth quarter worth $796,000. Finally, Daiwa Securities Group Inc. raised its stake in Henry Schein by 5.4% in the fourth quarter. Daiwa Securities Group Inc. now owns 16,486 shares of the company’s stock valued at $1,141,000 after purchasing an additional 850 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Trading Up 1.1 %

Shares of HSIC stock opened at $70.58 on Friday. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The stock has a market cap of $8.76 billion, a price-to-earnings ratio of 29.05, a PEG ratio of 2.13 and a beta of 0.90. The stock has a 50-day moving average of $74.84 and a 200-day moving average of $72.60.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter in the previous year, the business posted $0.66 EPS. The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. On average, equities research analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Analysts Set New Price Targets

HSIC has been the topic of several analyst reports. Jefferies Financial Group increased their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and lifted their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. UBS Group cut their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 26th. Wells Fargo & Company assumed coverage on shares of Henry Schein in a report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price target for the company. Finally, Mizuho initiated coverage on Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective on the stock. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $81.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.